isoborneol has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Li, X; Liu, J; Wang, S; Wei, Y; Wu, Y; Ye, T; Zhang, T | 1 |
| Liu, J; Liu, Y; Sun, J; Wei, C; Xie, W; Xu, M; Zhou, H | 1 |
| Han, L; Lu, W; Qin, J; Wang, J; Zhang, L | 1 |
3 other study(ies) available for isoborneol and Alzheimer Disease
| Article | Year |
|---|---|
Borneol-driven meningeal lymphatic drainage clears amyloid-β peptide to attenuate Alzheimer-like phenotype in mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Meninges; Mice; Mice, Transgenic; Nitric Oxide | 2023 |
Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; beta-Cyclodextrins; Blood-Brain Barrier; Camphanes; Cell Line, Tumor; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Synergism; Humans; Mice; Nanoconjugates; Oxidation-Reduction; Porosity; Protein Aggregation, Pathological; Reactive Oxygen Species; Resveratrol; Selenium; Specific Pathogen-Free Organisms | 2019 |
The use of borneol as an enhancer for targeting aprotinin-conjugated PEG-PLGA nanoparticles to the brain.
Topics: Alkaloids; Alzheimer Disease; Animals; Aprotinin; Behavior, Animal; Brain; Camphanes; Endothelial Cells; Male; Maze Learning; Mice; Mice, Nude; Nanoconjugates; Neuroprotective Agents; Polyesters; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tissue Distribution | 2013 |